肌肉骨骼放射学中的分子影像:我们将走向何方?
肌肉骨骼疾病是全球致残的主要原因之一,结构影像虽为多数肌骨疾病诊断的金标准,但各单一模态在炎症过程表征、炎症活动度定量及治疗反应评估方面特异性有限。这篇叙述性综述从结构解剖影像的优势与不足出发,重点阐述分子影像在非肿瘤性肌骨疾病评估中、尤其是监测治疗反应方面的前景。
要点
- 结构影像(X线、高频超声、CT、MRI)是多数肌骨疾病诊断金标准,但炎症表征与疗效评估特异性有限。
- 分子影像技术可能在克服上述局限方面发挥有前景的作用。
- 综述聚焦分子影像在非肿瘤性肌骨疾病中的应用,尤其关注其监测治疗反应的作用。
核心结论
- 分子影像技术可能在非肿瘤性肌骨疾病评估中发挥有前景的作用,尤其用于监测治疗反应。
研究设计与样本
- 叙述性综述,从结构解剖影像的优势与不足出发,聚焦分子影像在非肿瘤性肌骨疾病评估及治疗反应监测中的作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Musculoskeletal (MSK) pathologies are one of the leading causes of disability worldwide. However, treatment options and understanding of pathogenetic processes are still partially unclear, mainly due to a limited ability in early disease detection and response to therapy assessment. In this scenario, thanks to a strong technological advancement, structural imaging is currently established as the gold-standard of diagnosis in many MSK disorders but each single diagnostic modality (plain films, high-resolution ultrasound, computed tomography and magnetic resonance) still suffer by a low specificity regarding the characterization of inflammatory processes, the quantification of inflammatory activity levels, and the degree of response to therapy. To overcome these limitations, molecular imaging techniques may play a promising role. Starting from the strengths and weaknesses of structural anatomical imaging, the present narrative review aims to highlight the promising role of molecular imaging in the assessment of non-neoplastic MSK diseases with a special focus on its role to monitor treatment response.
引用
- Bauckneht M, Raffa S, Leale G, et al. Molecular imaging in MSK radiology: Where are we going? Eur J Radiol. 2021. PMID: 33951567. doi:10.1016/j.ejrad.2021.109737
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。